By using CDX2—a master regulator of intestinal lineage—as a seed node, BoNE traced upstream regulatory hubs capable of reinstating epithelial identity while suppressing CSC-associated programs in colorectal cancers. This evidence concerns the gene CDX2 and colorectal cancer.